Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.73 |
| ▸ | MAOB | P27338 | 1/20 | 0.73 |
| ▸ | ELANE | P08246 | 1/20 | 0.70 |
| ▸ | NQO1 | P15559 | 3/20 | 0.55 |
| ▸ | POR | P16435 | 3/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | S100A4 | P26447 | 3/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | METAP1 | P53582 | 2/20 | 0.47 |
| ▸ | PTPRC | P08575 | 3/20 | 0.44 |
| ▸ | USP8 | P40818 | 1/20 | 0.44 |
| ▸ | USP7 | Q93009 | 1/20 | 0.44 |
| ▸ | ALKBH3 | Q96Q83 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2610165 | 0.94 | ELANE (0.77) | MAOAMAOBELANENQO1POR | |
| SCHEMBL31674914 | 0.94 | ELANE (0.77) | MAOAMAOBELANENQO1POR | |
| SCHEMBL6036732 | 0.91 | ELANE (0.87) | MAOAMAOBELANENQO1POR | |
| SCHEMBL22799422 | 0.90 | ELANE (0.78) | MAOAMAOBELANENQO1POR | |
| SCHEMBL182959 | 0.89 | ELANE (0.86) | MAOAMAOBELANENQO1POR | |
| SCHEMBL12108763 | 0.89 | MAOA (0.73) | MAOAMAOBELANENQO1POR | |
| SCHEMBL583153 | 0.89 | ELANE (0.86) | MAOAMAOBELANENQO1POR | |
| SCHEMBL12553088 | 0.87 | MAOA (0.57) | MAOAMAOBELANENQO1POR | |
| SCHEMBL13647525 | 0.87 | S100A4 (0.75) | MAOAMAOBELANENQO1POR | |
| SCHEMBL16656188 | 0.85 | ELANE (0.79) | MAOAMAOBELANENQO1POR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7129008-B2 | Holographic recording material | LASER PHOTONICS TECHNOLOGY INC. (US) | 2006-10-31 | — | — | US | claimed |
| US-20040033423-A1 | Holographic recording material | LASER PHOTONICS TECHNOLOGY INC. | 2004-02-19 | — | — | US | claimed |
| EP-1675930-B1 | NEW MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF | MERCK PATENT GMBH (DE) | 2018-05-30 | — | — | EP | disclosed |
| WO-2015101215-A1 | 9,9,10,10-TETRAFLUORO-9,10-DIHYDROPHENANTHRENE HEPATITIS C VIRUS INHIBITOR AND APPLICATION THEREOF | 南京圣和药业股份有限公司 | 2015-07-09 | — | — | WO | disclosed |
| US-20130122367-A1 | LITHIUM PRIMARY CELL | PANASONIC CORPORATION (JP) | 2013-05-16 | — | — | US | disclosed |
| US-8338027-B2 | Phenanthrenequinone compound, electrode active material, and power storage device | PANASONIC CORPORATION (JP) | 2012-12-25 | — | — | US | disclosed |
| US-8173276-B2 | Materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2012-05-08 | — | — | US | disclosed |
| US-8173276-B2 | Materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2012-05-08 | — | — | US | disclosed |
| US-20100102305-A1 | MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF | MERCK PATENT GMBH (DE) | 2010-04-29 | — | — | US | disclosed |
| US-20100102305-A1 | MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF | MERCK PATENT GMBH (DE) | 2010-04-29 | — | — | US | disclosed |
| US-20100047688-A1 | PHENANTHRENEQUINONE COMPOUND, ELECTRODE ACTIVE MATERIAL, AND POWER STORAGE DEVICE | PANASONIC CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| US-7659540-B2 | Materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2010-02-09 | — | — | US | disclosed |
| US-20070080343-A1 | New materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070080343-A1 | New materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| US-7175958-B2 | Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same | RICOH COMPANY, LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7175958-B2 | Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same | RICOH COMPANY, LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7129008-B2 | Holographic recording material | LASER PHOTONICS TECHNOLOGY INC. (US) | 2006-10-31 | — | — | US | disclosed |
| US-20040033423-A1 | Holographic recording material | LASER PHOTONICS TECHNOLOGY INC. | 2004-02-19 | — | — | US | disclosed |
| US-20020068225-A1 | Holographic recording material | LASER PHOTONICS TECHNOLOGY INC. | 2002-06-06 | — | — | US | disclosed |
| US-6344297-B1 | POLYMERIZABLE ACRYLIC MONOMERS AND LIGHT ABSORBING PHENANTHRENEQUINONE DYES; SYMMETRIC CONCENTRATION DISTRIBUTION OF THE DYE | LASER PHOTONICS TECHNOLOGY INC. | 2002-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100047688-A1 | PHENANTHRENEQUINONE COMPOUND, ELECTRODE ACTIVE MATERIAL, AND POWER STORAGE DEVICE | RECQL, POLQ, COQ8A | MAOA 1110/4885MAOB 1588/4885ELANE 1543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.